Resources from the same session
Optimal selection of patients with untreated advanced renal carcinoma for combination and monotherapy regimens: Agents, combinations and emerging biomarkers
Presenter: Jens Bedke
Session: ESMO Colloquium supported by Eisai Europe Ltd - How to optimise efficacy and safety of targeted agent/IO management strategies in advanced solid tumours: Single agents, combinations and biomarkers
Resources:
Slides
Webcast
Optimal selection of patients with untreated advanced hepatocellular cancer for combination and monotherapy regimens: Agents, combinations and emerging biomarkers
Presenter: Masafumi Ikeda
Session: ESMO Colloquium supported by Eisai Europe Ltd - How to optimise efficacy and safety of targeted agent/IO management strategies in advanced solid tumours: Single agents, combinations and biomarkers
Resources:
Slides
Webcast
Optimal selection of patients with platinum-pretreated advanced endometrial carcinoma for combination and monotherapy regimens: Agents, combinations and emerging biomarkers
Presenter: Cristiana Sessa
Session: ESMO Colloquium supported by Eisai Europe Ltd - How to optimise efficacy and safety of targeted agent/IO management strategies in advanced solid tumours: Single agents, combinations and biomarkers
Resources:
Slides
Webcast
Proactive and reactive strategies for improving patient compliance and safety of VEGFR-TKI/immune checkpoint inhibitor combinations
Presenter: Giuseppe Procopio
Session: ESMO Colloquium supported by Eisai Europe Ltd - How to optimise efficacy and safety of targeted agent/IO management strategies in advanced solid tumours: Single agents, combinations and biomarkers
Resources:
Slides
Webcast